Basilard BioTech Inc

Basilard BioTech Inc. is a biotechnology company based in Temecula, California. With a team of three employees, the company has generated $2.5 million in revenue. Basilard BioTech specializes in the development of cell and gene therapies (CGT). Their flagship product, Celletto™, is a novel gene delivery technology platform designed to overcome the limitations of existing biological and ex-vivo gene delivery methods. Celletto™ utilizes a mechanical approach to gene delivery, known as mechanoporation, offering superior transfection and cell viability compared to traditional methods like electroporation. Celletto™ presents a significant advancement for both viral and non-viral gene delivery. In ex-vivo delivery, it surpasses industry-leading electroporation platforms in performance and yield. For viral delivery, Celletto™ offers enhanced scalability, safety, efficiency, versatility, and a lower cost compared to existing viral delivery methods. Additionally, Celletto™ stands as a superior platform for primary T cell engineering, outperforming both electroporation and viral delivery methods. For more information about Basilard BioTech and Celletto™, please visit their website at basilardbiotech.com.